Morning Market Losers

By: via Benzinga
Neostem (NYSE: NBS) shares dropped 23.30% to $5.20 after the company reported initial 'positive' data from Phase 2 PreSERVE AMI clinical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.